Harprit Singh: India’s Silent Transfusion Gap – What Policymakers Need to Know in 2026
Harprit Singh, Associate Director at Transfusion Technologies, Therapies, Solutions and Consultant in Transfusion Medicine at Alchemist Hospital, shared a post on LinkedIn:
“India’s Silent Transfusion Gap: What Policymakers Need to Know in 2026
India has made substantial progress in blood collection and safety standards over the years. Yet, alongside these achievements, a quieter challenge continues to surface in clinical settings.
It faces a transfusion systems gap.
Every year, hospitals reporting adequate collections still miss timely transfusion, plasma exchange, or transplant readiness when it matters most.
This gap is not about donor numbers but how blood moves through the health system.
Across tertiary hospitals, I see the same pattern:
- Blood centres work hard
- Clinicians work harder
- Outcomes still vary widely
Why?
Because blood centres and transfusion medicine are used interchangeably — often treated as a logistics function, not a clinical and strategic one.
Where the opportunity for strengthening systems lies:
- Reactive blood demand forecasting
- Component availability is tracked, but not clinical readiness
- Apheresis capacity is not integrated into ICU, transplant, or similar service delivery decision-making
- Data flows upward for reporting, not sideways for action
These are system design opportunities
Global guidance from the World Health Organization and national frameworks under MoHFW India consistently emphasise haemovigilance, traceability, and integration.
Implementation progress varies understandably across regions, hospital types, and resource settings.
The next phase of reform is an enabling architecture
An architecture that facilitates coordination, visibility, and prompt decision-making throughout various care pathways is essential.
As 2026 approaches, policymakers and health system leaders may find value in asking new questions: ‘How reliably did transfusion services support critical care, transplants, and emergency response when needed?’
Hospitals that close this gap see quieter benefits:
- Fewer last-minute escalations
- Better transplant readiness
- Lower wastage
- Higher public trust
This is where clinical expertise, operational leadership, and policy design naturally converge toward the rational and equitable use of blood.
Leadership prompt:
If you are shaping policy, accreditation, or large hospital systems, I’m always open to exchanging perspectives on building transfusion intelligence at scale. Many of the most meaningful improvements I’ve seen began with a single strategic conversation.
- Which part of your transfusion pathway would fail first if demand surged tomorrow?
- How prepared is your organisation for the next inflection point?”
David McIntosh, Founder and Chair of United Plasma Action, shared this post on LinkedIn, adding:
“This post from a knowledgeable front-line practitioner in India is good relevant reading for folks in other countries too!! ”
Stay updated with Hemostasis Today.
-
Oct 1, 2026, 15:44A Century of Von Willebrand Disease Awareness – EHC
-
Oct 1, 2026, 15:31Andreas Calatzis: The Power of Teamwork in Postpartum Hemorrhage
-
Oct 1, 2026, 15:09Halimat Olaniyan: The Role of Transfusion Medicine in Sickle Cell Disease Care
-
Oct 1, 2026, 14:58Samir Kumar Beura: Modern Approaches to Platelet Structure and Function
-
Oct 1, 2026, 14:39Understanding the FDA Pathway for Hematology Product Development – American Society of Hematology
-
Oct 1, 2026, 13:56Ravi C Dara: Advancing Red Cell Exchange in Sickle Cell Disease
-
Oct 1, 2026, 13:50Mateo Marin-Cuartas: What Matters After Aortic Valve Replacement in Younger Patients?
-
Oct 1, 2026, 13:17Anirban Sen Gupta: Sharing Ideas, Advancing Biomedical Innovation
-
Oct 1, 2026, 13:01Michael Honigberg: Clonal Hematopoiesis as a Driver of Aortic Valve Calcification